Monthly study medicine for adults with sleep apnea and overweight who use a breathing machine
Part of Brain & nervous system, Hormones & metabolism, Lungs & breathing, Mental health clinical trials.
This study tests an investigational medicine taken once a month for adults with moderate to severe sleep apnea who are overweight or have obesity and use a CPAP or similar breathing machine. It aims to see if the medicine improves sleep-related breathing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are overweight or have obesity (BMI of 27 or higher)
- You have been diagnosed with moderate to severe obstructive sleep apnea
- You currently use a breathing machine (like CPAP) for sleep apnea and plan to keep using it during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine called berobenatide to help people with overweight or obesity lose weight. The medicine may also help improve related health conditions like high blood pressure, high cholesterol, or type 2 diabetes.
This study tests an investigational medication called eloralintide to see if it can improve sleep apnea in people who are overweight or have obesity. You will receive either the study drug or a placebo (inactive shot), and your sleep and weight will be monitored over time.
This study tests an investigational medicine (HDM1005) for people who have both obesity and obstructive sleep apnea (where breathing stops during sleep) and who already use a CPAP machine. The goal is to see if the medicine can reduce breathing pauses and improve sleep quality compared to a placebo.
This study tests an investigational medicine given once a month to help Chinese adults with overweight or obesity lose weight. It is a placebo-controlled trial, meaning some participants will receive a dummy injection, and the study will compare the effects.
This study tests whether a new injectable medicine called NNC0487-0111 helps people with excess weight and moderate-to-severe obstructive sleep apnea (a condition where breathing stops repeatedly during sleep) lose weight and improve their sleep apnea—without needing a CPAP machine. The goal is to see if better weight loss can reduce sleep apnea symptoms.
This study tests an investigational injection for obstructive sleep apnea (a condition where breathing stops during sleep) in people who are overweight or have obesity. The treatment may help reduce sleep apnea events and improve sleep quality.
Hear when a new Apnea trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.